Yinglu Zhou

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Radical Prostatectomy

Chronic Lymphocytic Leukemia

Bioinformatics Analysis

Top Venues

Molecular cancer research : MCR

NPJ precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Inhye E Ahn, Danielle M Brander, Yue Ren, Yinglu Zhou, Svitlana Tyekucheva, Heather A Walker, Robert Black, Josie Montegaard, Alvaro J Alencar, Leyla Shune, Mohammad Omaira, Caron A Jacobson, Philippe Armand, Samuel Y Ng, Jennifer L Crombie, David C Fisher, Ann Steward LaCasce, Jon E Arnason, Ephraim P Hochberg, Ronald W Takvorian, Jeremy S Abramson, Jennifer R Brown, Matthew S Davids
Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL. Blood advances (2024)
Inhye E Ahn, Danielle M Brander, Yue Ren, Yinglu Zhou, Svitlana Tyekucheva, Heather A Walker, Robert Black, Josie Montegaard, Alvaro J Alencar, Leyla Shune, Mohammad Omaira, Caron A Jacobson, Philippe Armand, Samuel Y Ng, Jennifer Crombie, David C Fisher, Ann Steward LaCasce, Jon Arnason, Ephraim P Hochberg, Ronald W Takvorian, Jeremy S Abramson, Jennifer R Brown, Matthew S Davids
Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL. Blood advances 8 (4) (2024)
Inhye E Ahn, Danielle M Brander, Yue Ren, Yinglu Zhou, Svitlana Tyekucheva, Heather A Walker, Robert Black, Josie Montegaard, Alvaro J Alencar, Leyla Shune, Mohammad Omaira, Caron A Jacobson, Philippe Armand, Samuel Y Ng, Jennifer Crombie, David C Fisher, Ann Steward LaCasce, Jon Arnason, Ephraim P Hochberg, Ronald W Takvorian, Jeremy S Abramson, Jennifer R Brown, Matthew S Davids
Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL. Blood advances 8 (4) (2024)
Chaoran Ma, Yinglu Zhou, Giuseppe Nicolò Fanelli, Konrad H Stopsack, Michelangelo Fiorentino, Giorgia Zadra, Lorelei A Mucci, Massimo Loda, Svitlana Tyekucheva, Kathryn L Penney
The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate Cancer. Molecular cancer research : MCR 21 (3) (2023)
William Butler, Colin T McDowell, Qing Yang, Yiping He, Yue Zhao, J Spencer Hauck, Yinglu Zhou, Hong Zhang, Andrew J Armstrong, Daniel J George, Richard R Drake, Jiaoti Huang
Rewiring of the N-Glycome with prostate cancer progression and therapy resistance. NPJ precision oncology 7 (1) (2023)
Chaoran Ma, Yinglu Zhou, Giuseppe Nicolò Fanelli, Konrad H Stopsack, Michelangelo Fiorentino, Giorgia Zadra, Lorelei A Mucci, Massimo Loda, Svitlana Tyekucheva, Kathryn L Penney
The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate Cancer. Molecular cancer research : MCR 21 (3) (2023)
William Butler, Colin T McDowell, Qing Yang, Yiping He, Yue Zhao, J Spencer Hauck, Yinglu Zhou, Hong Zhang, Andrew J Armstrong, Daniel J George, Richard R Drake, Jiaoti Huang
Rewiring of the N-Glycome with prostate cancer progression and therapy resistance. NPJ precision oncology 7 (1) (2023)
Chaoran Ma, Yinglu Zhou, Giuseppe Nicolò Fanelli, Konrad H Stopsack, Michelangelo Fiorentino, Giorgia Zadra, Lorelei A Mucci, Massimo Loda, Svitlana Tyekucheva, Kathryn L Penney
The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate Cancer. Molecular cancer research : MCR 21 (3) (2023)
William Butler, Colin T McDowell, Qing Yang, Yiping He, Yue Zhao, J Spencer Hauck, Yinglu Zhou, Hong Zhang, Andrew J Armstrong, Daniel J George, Richard R Drake, Jiaoti Huang
Rewiring of the N-Glycome with prostate cancer progression and therapy resistance. NPJ precision oncology 7 (1) (2023)
Christine E Ryan, Danielle M Brander, Paul M Barr, Svitlana Tyekucheva, Liam R Hackett, Mary C Collins, Stacey M Fernandes, Yue Ren, Yinglu Zhou, Mikaela M McDonough, Heather A Walker, Monica R McEwan, Jeremy S Abramson, Eric D Jacobsen, Ann S LaCasce, David C Fisher, Jennifer R Brown, Matthew S Davids
A phase 1b study of ibrutinib in combination with obinutuzumab in patients with relapsed or refractory chronic lymphocytic leukemia. Leukemia (2023)
Chaoran Ma, Yinglu Zhou, Giuseppe Nicolò Fanelli, Konrad H Stopsack, Michelangelo Fiorentino, Giorgia Zadra, Lorelei A Mucci, Massimo Loda, Svitlana Tyekucheva, Kathryn L Penney
The prostate stromal transcriptome in aggressive and lethal prostate cancer. Molecular cancer research : MCR (2022)
Chaoran Ma, Yinglu Zhou, Giuseppe Nicolò Fanelli, Konrad H Stopsack, Michelangelo Fiorentino, Giorgia Zadra, Lorelei A Mucci, Massimo Loda, Svitlana Tyekucheva, Kathryn L Penney
The prostate stromal transcriptome in aggressive and lethal prostate cancer. Molecular cancer research : MCR (2022)
Aishath Naeem, Filippo Utro, Qing Wang, Justin Cha, Mauno Vihinen, Stephen P Martindale, Yinglu Zhou, Yue Ren, Svitlana Tyekucheva, Annette S Kim, Stacey M Fernandes, Gordon Saksena, Kahn Rhrissorrakrai, Chaya Levovitz, Brian P Danysh, Kara Slowik, Raquel A Jacobs, Matthew S Davids, James A Lederer, Rula Zain, Carl Inge Edvard Smith, Ignaty Leshchiner, Laxmi Parida, Gad Getz, Jennifer R Brown
Pirtobrutinib Targets BTK C481S in Ibrutinib-Resistant CLL but Second-Site BTK Mutations Lead to Resistance. Blood advances (2022)
Yanjing Li, Yiping He, William Butler, Lingfan Xu, Yan Chang, Kefeng Lei, Hong Zhang, Yinglu Zhou, Allen C Gao, Qingfu Zhang, Daniel G Taylor, Donghui Cheng, Suzette Farber-Katz, Rachid Karam, Tyler Landrith, Bing Li, Sitao Wu, Vickie Hsuan, Qing Yang, Hailiang Hu, Xu-Feng Chen, Melissa Flowers, Shannon J McCall, John K Lee, Bryan A Smith, Jung Wook Park, Andrew S Goldstein, Qianben Wang, Matthew B Rettig, Andrew J Armstrong, Qing Cheng, Jiaoti Huang
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer. Science translational medicine 11 (521) (2020)